TX-KAHUNA-WORKFORCE
6.2.2024 10:08:34 CET | Business Wire | Press release
Kahuna Workforce Solutions, the leading provider of skills and competency management software, has formed a strategic partnership with Norwegian operating services provider PXO AS to accelerate workforce competency in Norway’s booming energy sector, which is a significant stabilizer of the world’s oil and gas supply, particularly in meeting European demand.
The two companies, both of which already have established customers in Norway, have identified opportunities to jointly support the region’s growing demand for technically skilled professionals in the energy sector. The partnership specifically aims to improve operations readiness and assurance by combining Kahuna’s dynamic, digitized competency management platform with PXO’s extensive technical and field experience in a variety of operating production facilities offshore and onshore.
“PXO represents everything we look for in a partner as we strive to ensure successful and rapid adoption of competency-based training and development programs,” said Jai Shah, CEO of Kahuna Workforce Solutions. “As a company that works with many of the same customers as PXO, we’ve seen their expertise firsthand. It is clear they are the right partner to help us not only address the current needs of the energy industry but also pioneer innovative solutions that will shape the future of competency readiness and assurance in Norway.”
The collaboration comes at a critical time for the region, as Norway expects to draw nearly $22 billion in investments from oil and gas companies in 2024. The country is also leading the world toward cleaner energy solutions. Kahuna and PXO’s partnership will help Norwegian energy companies navigate this transition in a variety of ways, including streamlining skills validation and aligning operational standards with expanding ESG initiatives and emerging technologies.
“Just as we serve as a bridge between project and operation phases, Kahuna equips enterprises with validated competency data,” said Leif Olav Moe, CEO of PXO. “By uniting our technical and operational expertise with their cutting-edge competency management solutions, we are delivering a unique solution unlike anything the market has yet to provide—signifying our commitment to building a more skilled and competitive workforce to ascertain safer and more efficient operations.”
"At Kahuna, we are empowering organizations throughout the energy value chain by providing validated competency data and unique insights. This enables a deep understanding of workforce capabilities for seamless operational execution, in addition to aligning talent supply with demand and maximizing the return on investment in technical training,” Shah said. “When you combine our capabilities with PXO’s extensive experience in supporting operations with strategic training and competency services, there is no other competency management solution that comes close to building a skilled, safe, compliant, and competitive workforce.”
About Kahuna Workforce Solutions
Kahuna Workforce Solutions is the only skills management software built for operations, learning, and human resources. Kahuna equips enterprise organizations with validated skills data to understand workforce capability, align talent supply and demand, and increase the return on training investment. Across a wide array of industries including healthcare, energy, manufacturing, and aerospace, Kahuna helps organizations build a more skilled, competitive workforce. For more information, visit https://kahunaworkforce.com/.
About PXO
PXO's services are mainly within the petroleum industry with field operating companies as clients, however, the services are also applied within other industry segments, such as shipping, renewable energy and aquaculture.
PXO increases awareness of safety barriers and their functions to improve efficiency and safety in field operations. Exposed to increasingly demanding requirements from authorities, clients, suppliers, and other stakeholders as regards knowledge and experience require systematic and targeted competence development of operations personnel in particular, extending from planning through construction & start-up and into regular operations. PXO ensures that prevailing competence requirements are met and followed up through various measures:
- Systematization of specific competence requirements
- Development of model-based interactive management tools (portal solutions)
- Harmonization of job descriptions and work processes
- Development and execution of training plans through interactive computer based training and practical On the Job Training (OJT) programmes.
PXO is focused on the interaction between people, organization and technology as a means to optimize, integrate and align work processes and technical equipment for robust and safe overall solutions.
For more information, visit https://www.pxo.no/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240206626623/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
